首页> 外文OA文献 >Antagonistic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors
【2h】

Antagonistic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors

机译:CCAAT增强子结合蛋白-α和Pax5在常见淋巴祖细胞的髓样或淋巴谱系选择中的拮抗作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Lymphoid lineage-committed progenitors, such as common lymphoid progenitors (CLPs), maintain a latent myeloid differentiation potential, which can be initiated by stimulation through exogenously expressed cytokine receptors, including IL-2 receptors. Here we show that the transcription factor CCAAT enhancer-binding protein-α (C/EBPα) is promptly up-regulated in CLPs upon ectopic IL-2 stimulation. Enforced C/EBPα expression is sufficient to initiate myeloid differentiation from CLPs, as well as from proT and proB cells, even though proB cells do not give rise to myeloid cells after ectopic IL-2 stimulation. Expression of Pax5, a B lymphoid-affiliated transcription factor, is completely suppressed by enforced C/EBPα but not by ectopic IL-2 stimulation in proB cells. Introduction of Pax5 blocks ectopic IL-2 receptor-mediated myeloid lineage conversion in CLPs. These data suggest that C/EBPα is a proximal target of cytokine-induced lineage conversion in lymphoid progenitors. Furthermore, complete loss of Pax5 expression triggered by up-regulation of C/EBPα is a critical event for lineage conversion from lymphoid to myeloid lineage in CLPs and proB cells.
机译:淋巴谱系提交的祖细胞(例如常见的淋巴祖细胞(CLP))保持潜在的骨髓分化潜能,可以通过外源表达的细胞因子受体(包括IL-2受体)刺激来启动。在这里,我们显示了异位IL-2刺激后,CLP中的转录因子CCAAT增强子结合蛋白-α(C /EBPα)迅速上调。强制的C /EBPα表达足以启动CLP,proT和proB细胞的髓样分化,即使proB细胞在异位IL-2刺激后不会产生髓样细胞。 Pax5(一种B淋巴相关的转录因子)的表达可通过强制C /EBPα来完全抑制,但不能通过proB细胞中的异位IL-2刺激来抑制。 Pax5的引入可阻止CLP中异位IL-2受体介导的髓系谱系转化。这些数据表明,C /EBPα是淋巴样祖细胞中细胞因子诱导的谱系转化的近端靶标。此外,由C /EBPα的上调引发的Pax5表达的完全丧失是CLP和proB细胞中从淋巴样谱系转化为髓样谱系的谱系转化的关键事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号